WASHINGTON (dpa-AFX) - PolarityTE, Inc. (PTE) said its subsidiary, Arches Research, has entered into a strategic partnership with Co-Diagnostics, Inc. (CODX) to expand COVID-19 testing operations. Arches will provide COVID-19 testing for customers referred by Co-Diagnostics. Co-Diagnostics will provide to Arches testing equipment in exchange for Arches' commitment to use only Co-Diagnostics tests on the equipment.
Arches received a CLIA certificate of registration at the end of April and began testing for COVID-19 shortly thereafter.
David Seaburg, CEO of PolarityTE, said: 'We look forward to growing this collaboration with Co-Diagnostics to potentially include additional molecular diagnostic testing opportunities in the future.'
Copyright RTT News/dpa-AFX
© 2020 AFX News
